Altogether, these results suggest that the overexpression of TERT was associated with increased resistance to BRAF and MEK inhibition in BRAF-mutated melanoma cell lines by a mechanism involving the reactivation of the MAPK pathway. The gene discussed is MAP2K7; the disease is melanoma.